Jigna Bhupendra Prajapati

Dr. Jigna Bhupendra Prajapati

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2025 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
JTJunaid Ishaq Tantray
Junaid Ishaq Tantray
APAkhilesh Patel
Akhilesh Patel
HPHiba Parveen
Hiba Parveen
Bhupendra G PrajapatiBhupendra G Prajapati
Bhupendra G Prajapati
JPJigna Bhupendra Prajapati
Jigna Bhupendra Prajapati

30 March 2023
Verified
Book Chapter
Closed access
PDF file
JPJigna Bhupendra Prajapati
Jigna Bhupendra Prajapati
HPHimanshu Paliwal
Himanshu Paliwal
Bhupendra G PrajapatiBhupendra G Prajapati
Bhupendra G Prajapati
SSSurovi Saikia
Surovi Saikia
RPRajiv Pandey
Rajiv Pandey

15 January 2024 in SN Social Sciences
Verified
Journal Article
Closed access
PDF file
JPJigna Bhupendra Prajapati
Jigna Bhupendra Prajapati
Ashwini KumarAshwini Kumar
Ashwini Kumar
Sudarshan SinghSudarshan Singh
Sudarshan Singh
Bhupendra G PrajapatiBhupendra G Prajapati
Bhupendra G Prajapati
YTYash Thakar
Yash Thakar
AVAmit Ved
Amit Ved

1 November 2024 in Current Respiratory Medicine Reviews
Verified
Journal Article
Closed access
PDF file
BBBiswajit Basu
Biswajit Basu
SDSrabona Dutta
Srabona Dutta
Monosiz RahamanMonosiz Rahaman
Monosiz Rahaman
ABAnirbandeep Bose
Anirbandeep Bose
SDSourav Das
Sourav Das
Bhupendra G PrajapatiBhupendra G Prajapati
Bhupendra G Prajapati
: Cystic Fibrosis (CF) is a fatal hereditary condition marked by thicker mucus production, which can cause problems with the digestive and respiratory systems. The quality of life and survival rates of CF patients can be improved by early identification and individualized therapy measures. With an emphasis on its applications in diagnosis and therapy, this paper investigates how Artificial Intelligence (AI) is transforming the management of Cystic Fibrosis (CF). AI-powered algorithms are revolutionizing CF diagnosis by utilizing huge genetic, clinical, and imaging data databases. In order to identify CF mutations quickly and precisely, machine learning methods evaluate genomic profiles. Furthermore, AI-driven imaging analysis helps to identify lung and gastrointestinal issues linked to cystic fibrosis early and allows for prompt treatment. Additionally, AI aids in individualized CF therapy by anticipating how patients will react to already available medications and enabling customized treatment regimens. Drug repurposing algorithms find prospective candidates from already-approved drugs, advancing treatment choices. Additionally, AI supports the optimization of pharmacological combinations, enhancing therapeutic results while minimizing side effects. AI also helps with patient stratification by connecting people with CF mutations to therapies that are best for their genetic profiles. Improved treatment effectiveness is promised by this tailored strategy. The transformational potential of artificial intelligence (AI) in the field of cystic fibrosis is highlighted in this review, from early identification to individualized medication, bringing hope for better patient outcomes, and eventually prolonging the lives of people with this difficult ailment.

30 March 2023
Verified
Book Chapter
Closed access
PDF file
DMDhaval Mehta
Dhaval Mehta
ARAmol Ranadive
Amol Ranadive
JPJigna Bhupendra Prajapati
Jigna Bhupendra Prajapati
RPRajiv Pandey
Rajiv Pandey